WASHINGTON, July 22 (Reuters) - Johnson & Johnson Inc
subsidiary Acclarent Inc., a California-based medical
device manufacturer, has agreed to pay $18 million to resolve
allegations that it caused healthcare providers to submit false
claims to Medicare and other federal healthcare programs, the
Justice Department said on Friday.
Read more
No comments:
Post a Comment